Bath, United Kingdom

John Nicholas Staniforth

USPTO Granted Patents = 83 

 

 

Average Co-Inventor Count = 2.2

ph-index = 29

Forward Citations = 2,270(Granted Patents)

Forward Citations (Not Self Cited) = 2,004(Dec 10, 2025)


Location History:

  • Bath, GB (1989 - 2017)
  • Chippenham, GB (2010 - 2021)
  • Wiltshire, GB (2011 - 2021)

Company Filing History:

goldMedal33 out of 71 
 
Vectura Gmbh
 patents
silverMedal18 out of 47 
 
Edward Mendell Co., Inc.
 patents
bronzeMedal3 out of 3 
 
Pharmakodex Limited
 patents
43 out of 7 
 
Phoqus Pharmaceuticals Limited
 patents
53 out of 9 
 
Sosei R&d Ltd.
 patents
62 out of 12 
 
Hoechst (uk) Limited
 patents
72 out of 157 
 
Ranbaxy Laboratories, Inc.
 patents
82 out of 48 
 
The University of Bath
 patents
92 out of 4 
 
J. Rettenmaier & Soehne Gmbh & Co. Kg
 patents
102 out of 11 
 
Penwest Pharmaceuticals Company
 patents
112 out of 11 
 
Britannia Pharmaceuticals Limited
 patents
122 out of 2 
 
Andi-ventis Limited
 patents
131 out of 1 
 
Forum Chemicals Ltd.
 patent
141 out of 1 
 
Co-ordinated Drug Development Limited
 patent
151 out of 1 
 
University of Bath (british Corp.)
 patent
161 out of 4 
 
Phoqus Limited
 patents
171 out of 1 
 
J. Rettenmaier & Soehne Gmbh + Co. Kg
 patent
181 out of 1,513 
 
Conopco, Inc.
 patents
191 out of 1 
 
Vectura Drug Delivery
 patent
201 out of 1 
 
Vectura Limited (01696917)
 patent
211 out of 832,891 
Other
 patents

Years Active: 1989-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pharmaceutical Compositions
Inhalation Formulations
Dry Powder Inhalers
Carrier Particles
Respiratory Diseases
Mucoactive Agents
Topical Formulations
Controlled Release Insufflation
Drug Delivery Systems
Electrostatic Coating
Microparticles
Oral Drug Delivery
83 patents (USPTO):Explore Patents

Title: John Nicholas Staniforth: Pioneering Pharmacist Inventor

Introduction:

John Nicholas Staniforth, hailed from Bath, GB, is a prolific inventor in the field of pharmaceutical compositions with an impressive 37 patents to his name. His groundbreaking work has revolutionized the way inhalable pharmaceutical compositions are prepared and utilized.

Latest Patents:

One of Staniforth's latest patents includes a method for making composite active particles for use in a pharmaceutical composition for pulmonary administration. This method involves a milling step that enhances the dispersal of the composite active particles upon inhaler actuation. Another significant patent is a method for creating composite excipient particles for inhalable pharmaceutical compositions, which boasts small size product particles with low energy input during milling.

Career Highlights:

Staniforth has left an indelible mark on the pharmaceutical industry through his tenure at innovative companies such as Vectura Gmbh and Pharmakodex Limited. His relentless pursuit of excellence and unwavering dedication to advancing pharmaceutical technologies have earned him a reputable position in the field.

Collaborations:

Throughout his career, Staniforth has collaborated with esteemed professionals in the field, including David Alexander Vodden Morton and Rossella Musa. These collaborations have led to the development of cutting-edge pharmaceutical inventions and propelled the industry forward.

Conclusion:

John Nicholas Staniforth's ingenuity and commitment to innovation have significantly impacted the pharmaceutical landscape. His patents and collaborations stand as a testament to his remarkable contributions to the field of pharmaceutical compositions, inspiring future generations of inventors to push the boundaries of what is possible in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…